Form 4 for MRX Marex Group Ltd
Accepted 2026-04-22 16:05:09 ET · period of report 2026-04-20 · accession 0001193125-26-170353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-04-22 16:05 | 2026-04-20 | MRX | Van Den Born Simon | Pres | S - Sale | $50.95 | -13.3K | 1.51M | -0.9% | -$675.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-04-20 | S | D | 12,624 | $50.92 | 1,509,605 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on December 12, 2025. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $50.51 to $51.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Ordinary Shares | 2026-04-20 | S | D | 641 | $51.71 | 1,508,964 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on December 12, 2025. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $51.56 to $52.115 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F4) The number of ordinary shares reported herein includes 383,741 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |